Kelsee

Dienogest, the active ingredient in Kelsee, is a combined oral contraceptive presented as a 0.03 mg dienogest / 0.02 mg ethinylestradiol tablet for oral use. Together with ethinylestradiol, it works to prevent pregnancy in women of reproductive age by inhibiting ovulation and modifying cervical mucus.

GNH USA supplies Kelsee as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU regulatory standards and is manufactured under GMP conditions for global distribution.

Kelsee, a combined oral contraceptive, is indicated for hormonal contraception in women.

Prevention of pregnancy: provides reliable contraceptive protection when taken as directed. Regulation of menstrual cycle: helps establish predictable bleeding patterns. Treatment of moderate acne: reduces androgen‑driven skin lesions in some users.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: temporary swelling or discomfort. - Headache: occasional tension‑type headache. - Breakthrough bleeding: spotting between periods. - Mood changes: irritability or mood swings. - Weight gain: slight increase in body weight.

Serious or Rare Side Effects: - Venous thromboembolism: deep vein thrombosis or pulmonary embolism. - Arterial thrombosis: stroke or myocardial infarction. - Severe hypertension: sudden rise in blood pressure. - Hepatic adenoma: benign liver tumor. - Anaphylaxis: life‑threatening allergic reaction. - Visual disturbances: sudden loss of vision or blurred sight.

Before prescribing Kelsee, consider the following precautions: - Contraindicated in pregnancy: product is Category X and must not be used. - History of thromboembolic disorders: increased risk of clot formation. - Smoking over age 35: elevated cardiovascular risk. - Uncontrolled hypertension: may exacerbate blood pressure. - Liver disease: impaired metabolism may alter drug levels. - Store at room temperature below 25°C: keep in the original pack, protect from moisture and light.

Kelsee may interact with other medicines as follows:

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce contraceptive efficacy. - Anticoagulants (e.g., warfarin): may increase clotting risk. - Hormonal breast cancer therapies (e.g., tamoxifen): may diminish contraceptive effect.

Moderate Interactions (Monitor Closely): - Antifungals such as ketoconazole: can raise hormone concentrations. - Certain antibiotics (e.g., tetracycline): may slightly lower effectiveness. - St. John’s wort: herbal inducer that may decrease plasma levels.